Dechra Pharmaceuticals PLC

LSE:DPH Voorraadrapport

Marktkapitalisatie: UK£4.4b

Dechra Pharmaceuticals Toekomstige groei

Future criteriumcontroles 4/6

Dechra Pharmaceuticals zal naar verwachting groeien in winst en omzet met respectievelijk 62.5% en 7.9% per jaar. De winst per aandeel zal naar verwachting groeien met 89.8% per jaar. Het rendement op het eigen vermogen zal over 3 jaar naar verwachting 19.8% zijn.

Belangrijke informatie

62.5%

Groei van de winst

89.8%

Groei van de winst per aandeel

Pharmaceuticals winstgroei18.4%
Inkomstengroei7.9%
Toekomstig rendement op eigen vermogen19.8%
Dekking van analisten

Low

Laatst bijgewerkt03 Jan 2024

Recente toekomstige groei-updates

Recent updates

Dechra Pharmaceuticals (LON:DPH) Takes On Some Risk With Its Use Of Debt

May 31
Dechra Pharmaceuticals (LON:DPH) Takes On Some Risk With Its Use Of Debt

A Look At The Intrinsic Value Of Dechra Pharmaceuticals PLC (LON:DPH)

Mar 28
A Look At The Intrinsic Value Of Dechra Pharmaceuticals PLC (LON:DPH)

We Think Dechra Pharmaceuticals (LON:DPH) Is Taking Some Risk With Its Debt

Mar 02
We Think Dechra Pharmaceuticals (LON:DPH) Is Taking Some Risk With Its Debt

Dechra Pharmaceuticals' (LON:DPH) Dividend Will Be Increased To £0.125

Mar 02
Dechra Pharmaceuticals' (LON:DPH) Dividend Will Be Increased To £0.125

Estimating The Intrinsic Value Of Dechra Pharmaceuticals PLC (LON:DPH)

Dec 09
Estimating The Intrinsic Value Of Dechra Pharmaceuticals PLC (LON:DPH)

Dechra Pharmaceuticals (LON:DPH) Is Increasing Its Dividend To £0.3289

Oct 06
Dechra Pharmaceuticals (LON:DPH) Is Increasing Its Dividend To £0.3289

Dechra Pharmaceuticals (LON:DPH) Is Paying Out A Larger Dividend Than Last Year

Sep 22
Dechra Pharmaceuticals (LON:DPH) Is Paying Out A Larger Dividend Than Last Year

Dechra Pharmaceuticals (LON:DPH) Will Pay A Larger Dividend Than Last Year At £0.3289

Sep 08
Dechra Pharmaceuticals (LON:DPH) Will Pay A Larger Dividend Than Last Year At £0.3289

Estimating The Intrinsic Value Of Dechra Pharmaceuticals PLC (LON:DPH)

Aug 18
Estimating The Intrinsic Value Of Dechra Pharmaceuticals PLC (LON:DPH)

Do Dechra Pharmaceuticals' (LON:DPH) Earnings Warrant Your Attention?

Aug 02
Do Dechra Pharmaceuticals' (LON:DPH) Earnings Warrant Your Attention?

These 4 Measures Indicate That Dechra Pharmaceuticals (LON:DPH) Is Using Debt Reasonably Well

Jun 10
These 4 Measures Indicate That Dechra Pharmaceuticals (LON:DPH) Is Using Debt Reasonably Well

Calculating The Fair Value Of Dechra Pharmaceuticals PLC (LON:DPH)

May 08
Calculating The Fair Value Of Dechra Pharmaceuticals PLC (LON:DPH)

Do Dechra Pharmaceuticals's (LON:DPH) Earnings Warrant Your Attention?

Apr 22
Do Dechra Pharmaceuticals's (LON:DPH) Earnings Warrant Your Attention?

Dechra Pharmaceuticals (LON:DPH) Is Increasing Its Dividend To UK£0.12

Feb 23
Dechra Pharmaceuticals (LON:DPH) Is Increasing Its Dividend To UK£0.12

Is Dechra Pharmaceuticals PLC (LON:DPH) Expensive For A Reason? A Look At Its Intrinsic Value

Jan 29
Is Dechra Pharmaceuticals PLC (LON:DPH) Expensive For A Reason? A Look At Its Intrinsic Value

Is Now The Time To Put Dechra Pharmaceuticals (LON:DPH) On Your Watchlist?

Jan 11
Is Now The Time To Put Dechra Pharmaceuticals (LON:DPH) On Your Watchlist?

Here's Why Dechra Pharmaceuticals (LON:DPH) Can Manage Its Debt Responsibly

Dec 04
Here's Why Dechra Pharmaceuticals (LON:DPH) Can Manage Its Debt Responsibly

It Looks Like Shareholders Would Probably Approve Dechra Pharmaceuticals PLC's (LON:DPH) CEO Compensation Package

Oct 15
It Looks Like Shareholders Would Probably Approve Dechra Pharmaceuticals PLC's (LON:DPH) CEO Compensation Package

Dechra Pharmaceuticals' (LON:DPH) Upcoming Dividend Will Be Larger Than Last Year's

Sep 25
Dechra Pharmaceuticals' (LON:DPH) Upcoming Dividend Will Be Larger Than Last Year's

Dechra Pharmaceuticals (LON:DPH) Will Pay A Larger Dividend Than Last Year At UK£0.29

Sep 11
Dechra Pharmaceuticals (LON:DPH) Will Pay A Larger Dividend Than Last Year At UK£0.29

With EPS Growth And More, Dechra Pharmaceuticals (LON:DPH) Is Interesting

Sep 08
With EPS Growth And More, Dechra Pharmaceuticals (LON:DPH) Is Interesting

Is Dechra Pharmaceuticals PLC (LON:DPH) Worth UK£43.4 Based On Its Intrinsic Value?

Jun 17
Is Dechra Pharmaceuticals PLC (LON:DPH) Worth UK£43.4 Based On Its Intrinsic Value?

Is Dechra Pharmaceuticals PLC (LON:DPH) A Smart Choice For Dividend Investors?

Apr 09
Is Dechra Pharmaceuticals PLC (LON:DPH) A Smart Choice For Dividend Investors?

Dechra Pharmaceuticals (LON:DPH) Has A Pretty Healthy Balance Sheet

Mar 05
Dechra Pharmaceuticals (LON:DPH) Has A Pretty Healthy Balance Sheet

Are Dechra Pharmaceuticals' (LON:DPH) Statutory Earnings A Good Reflection Of Its Earnings Potential?

Feb 17
Are Dechra Pharmaceuticals' (LON:DPH) Statutory Earnings A Good Reflection Of Its Earnings Potential?

Dechra Pharmaceuticals PLC (LON:DPH) Is Going Strong But Fundamentals Appear To Be Mixed : Is There A Clear Direction For The Stock?

Feb 02
Dechra Pharmaceuticals PLC (LON:DPH) Is Going Strong But Fundamentals Appear To Be Mixed : Is There A Clear Direction For The Stock?

Winst- en omzetgroeiprognoses

LSE:DPH - Toekomstschattingen van analisten en financiële gegevens uit het verleden (GBP Millions )
DatumInkomstenInkomstenVrije kasstroomGeldmiddelen uit operationele activiteitenGem. Aantal analisten
6/30/2026954187N/AN/A1
6/30/20259041231601825
6/30/20248371021421632
6/30/2023762-283364N/A
3/31/202374463975N/A
12/31/2022727404586N/A
9/30/20227044945105N/A
6/30/20226825845123N/A
3/31/20226616648121N/A
12/31/20216417351119N/A
9/30/2021624643104N/A
6/30/202160856-4589N/A
3/31/202158750-45102N/A
12/31/202056644-44114N/A
9/30/2020541397110N/A
6/30/20205153457106N/A
3/31/2020507315791N/A
12/31/2019499295776N/A
9/30/2019490305879N/A
6/30/2019482315982N/A
3/31/2019463286182N/A
12/31/2018444256281N/A
9/30/2018426305773N/A
6/30/2018407365164N/A
3/31/2018394405769N/A
12/31/2017381436375N/A
9/30/2017370356576N/A
6/30/2017359266777N/A
3/31/201733419N/A69N/A
12/31/201630911N/A62N/A
9/30/201627812N/A53N/A
6/30/201624813N/A44N/A
3/31/201623017N/A43N/A
12/31/201521320N/A42N/A
9/30/201520820N/A42N/A
6/30/201520319N/A41N/A
3/31/201520121N/A41N/A
12/31/201419922N/A42N/A
9/30/201419621N/A27N/A
6/30/201419419N/A11N/A
12/31/201319314N/A25N/A
9/30/201319113N/A31N/A
6/30/201318911N/A37N/A

Toekomstige groeivoorspellingen analisten

Verdiensten versus spaarpercentage: Er wordt voorspeld dat DPH de komende 3 jaar winstgevend zal worden, wat wordt beschouwd als een snellere groei dan de spaarquote ( 1.5% ).

Winst versus markt: Er wordt verwacht dat DPH de komende 3 jaar winstgevend zal worden. Dit wordt gezien als een groei die boven het gemiddelde van de markt ligt.

Hoge groeiwinsten: Er wordt verwacht dat DPH binnen 3 jaar winstgevend zal worden.

Omzet versus markt: De omzet van DPH ( 7.9% per jaar) zal naar verwachting sneller groeien dan de markt UK ( 3.6% per jaar).

Hoge groei-inkomsten: De omzet van DPH ( 7.9% per jaar) zal naar verwachting langzamer groeien dan 20% per jaar.


Groeiprognoses winst per aandeel


Toekomstig rendement op eigen vermogen

Toekomstige ROE: Het rendement op eigen vermogen DPH zal naar verwachting over 3 jaar laag zijn ( 19.8 %).


Ontdek groeibedrijven